Nucleated RBC Manual Percent

This test measures the percentage of red blood cells on a blood smear that still have a nucleus, called nucleated red blood cells. Mature red cells in the bloodstream normally do not have a nucleus, so finding nucleated forms can signal that very young red cell precursors have entered the circulation.

A trained technologist examines a stained blood smear under a microscope and manually counts nucleated red cells in relation to other cells, then reports the result as a percent. This review is often performed when an automated blood counter flags abnormalities, when a clinician requests a smear review, or in newborns and certain clinical situations.

The presence of nucleated red blood cells can be a marker of bone marrow activity under stress, such as significant anemia, blood loss, hemolysis, low oxygen states, severe infection, or disorders that affect the marrow. In newborns, nucleated red cells can be expected for a short period and are interpreted differently than in older children and adults.

Clinicians use this result together with your complete blood count, blood smear findings, and your symptoms to narrow possible causes and guide next steps. The test itself is performed on a standard blood sample; risks are limited to minor issues from the blood draw, such as brief discomfort or bruising.

Your result is interpreted in the context of your age, health status, and other blood tests. In adults, nucleated red blood cells are usually not seen; if they appear, your clinician will consider recent events like bleeding, hemolysis, hypoxia, or recovery after marrow suppression. A higher or persistent percentage may prompt additional tests to look for hemolysis, marrow disorders, infection, or oxygen delivery problems.

For infants, especially in the first days of life, nucleated red cells can be part of normal transition and are tracked over time. If your result is unexpected, your clinician may repeat the smear, review automated counts, and order complementary tests such as a reticulocyte count, hemoglobin, markers of hemolysis, or imaging, and will discuss whether treatment or observation is appropriate.